127:
in 1996 as a clinical scientist and was promoted in 2002 to Vice
President of Medical Affairs. In 2002 Barron was promoted to vice president of medical affairs and in 2003 he became the senior vice president of development. In 2004 he was appointed chief medical officer and in 2009 he was appointed
134:
On
November 8, 2017, Barron became the new CSO and research chief at GlaxoSmithKline amid a shake-up from its new CEO Emma Walmsley. Barron was quoted: "GSK is a company with a rich history of innovation, with many talented scientists who care deeply about translating great science into therapies
138:
In April 2019, it was publicly reported that Barron spent excessively on travel expenses during the previous year. The total expenses exceeded $ 807,000 (£620,000). Shareholders, investors, and rank-and-file employees have all expressed concern tilting towards outrage that he has been allow to
248:
135:
that make a meaningful difference for patients. I believe there is a significant opportunity to accelerate this effort and am looking forward to joining Emma and the team on this mission.”
604:
609:
131:
On
September 18, 2013, Barron was named President of Research and Development of Calico, a new company focusing on the biology of aging. The company was created and funded by Google.
599:
594:
249:"What kind of biotech startup wins a $ 3B syndicate, woos a gallery of marquee scientists and recruits GSK's Hal Barron as CEO in a stunner? Let Rick Klausner explain"
142:
In
January 2022, it was announced that Barron will join Altos starting on 1 August 2022 at newly created biotech company Altos Labs, based in San Francisco.
304:
589:
202:
146:
68:
41:
475:
355:
629:
448:
619:
198:
32:
380:
614:
584:
170:
634:
624:
424:"Google announces Calico, a new company focused on health and well-being – News announcements – News from Google – Google"
95:(born 1962) is an American clinician-scientist and drug developer who served as president of research and development at
574:
564:
111:. He has served as executive vice president, head of global product development, and chief medical officer of
579:
194:
569:
100:
559:
423:
528:
359:
331:
275:
178:
174:
483:
182:
80:
112:
108:
107:
in August of that year. Prior to this he served as president of research and development at
72:
507:
449:"Roche, Calico vet Hal Barron takes GSK R&D hot seat, as Vallance out - FierceBiotech"
96:
37:
253:
553:
154:
309:
166:
150:
332:"I'm excited to announce Calico, a new company that will focus on health and w..."
356:"Roche - Roche and Genentech announce organizational and leadership decisions"
279:
162:
158:
104:
487:
139:
spend so freely while others are constrained and employee layoffs continue.
124:
76:
58:
305:"GSK's top scientist jumps ship in new blow for pharmaceutical firm"
197:
and holds a
Bachelor of Science degree in engineering physics from
476:"GSK's jet-set scientist racks up travel bill worth nearly $ 800k"
99:
from March 2018 until 2022, when he resigned in order to join the
222:
201:. He completed his training in medicine and cardiology at the
405:
177:
161:. He has been issued several patents for his work in
381:"Genentech: Press Releases - Tuesday, May 14, 2002"
64:
54:
28:
21:
605:University of California, San Francisco faculty
157:, and Associate Clinical Professor of Medicine/
16:American clinician-scientist and drug developer
610:University of California, San Francisco alumni
600:Washington University in St. Louis physicists
298:
296:
8:
169:, and has published more than 80 papers in
145:Barron's current academic positions at the
18:
595:Washington University in St. Louis alumni
193:Barron received his medical degree from
214:
203:University of California, San Francisco
149:include Associate Adjunct Professor of
147:University of California, San Francisco
69:University of California, San Francisco
42:University of California, San Francisco
7:
474:Mkandawire, Vinjeru (2019-04-14).
303:Kollewe, Julia (19 January 2022).
276:"Altos Labs: Executive Leadership"
247:Carroll, John (January 19, 2022).
199:Washington University in St. Louis
33:Washington University in St. Louis
14:
171:peer-reviewed scientific journals
529:"Hal Barron – Juno Therapeutics"
590:Yale School of Medicine alumni
1:
630:American corporate directors
651:
128:executive vice president.
620:American biostatisticians
173:. He was a member of the
86:
47:
615:American epidemiologists
585:Hoffmann-La Roche people
428:Googlepress.blogspot.com
195:Yale School of Medicine
635:American transhumanists
625:American cardiologists
101:cellular reprogramming
533:Junotherapeutics.com
179:board of directors
175:board of directors
455:. 8 November 2017
453:Fiercebiotech.com
183:Juno Therapeutics
90:
89:
81:Hoffmann-La Roche
49:Scientific career
642:
575:Genentech people
565:Biotechnologists
544:
543:
541:
539:
525:
519:
518:
516:
514:
504:
498:
497:
495:
494:
471:
465:
464:
462:
460:
445:
439:
438:
436:
434:
420:
414:
413:
402:
396:
395:
393:
391:
377:
371:
370:
368:
367:
358:. Archived from
352:
346:
345:
343:
341:
328:
322:
321:
319:
317:
300:
291:
290:
288:
286:
272:
266:
265:
263:
261:
244:
238:
237:
235:
233:
219:
113:Hoffman-La Roche
73:Calico (company)
19:
650:
649:
645:
644:
643:
641:
640:
639:
550:
549:
548:
547:
537:
535:
527:
526:
522:
512:
510:
508:"Pubmed search"
506:
505:
501:
492:
490:
473:
472:
468:
458:
456:
447:
446:
442:
432:
430:
422:
421:
417:
404:
403:
399:
389:
387:
379:
378:
374:
365:
363:
354:
353:
349:
339:
337:
335:Plus.google.com
330:
329:
325:
315:
313:
302:
301:
294:
284:
282:
274:
273:
269:
259:
257:
246:
245:
241:
231:
229:
221:
220:
216:
211:
191:
121:
97:GlaxoSmithKline
38:Yale University
36:
29:Alma mater
24:
17:
12:
11:
5:
648:
646:
638:
637:
632:
627:
622:
617:
612:
607:
602:
597:
592:
587:
582:
580:GSK plc people
577:
572:
567:
562:
552:
551:
546:
545:
520:
499:
466:
440:
415:
410:calicolabs.com
397:
372:
347:
323:
292:
267:
254:Endpoints News
239:
213:
212:
210:
207:
190:
187:
123:Barron joined
120:
117:
88:
87:
84:
83:
66:
62:
61:
56:
52:
51:
45:
44:
30:
26:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
647:
636:
633:
631:
628:
626:
623:
621:
618:
616:
613:
611:
608:
606:
603:
601:
598:
596:
593:
591:
588:
586:
583:
581:
578:
576:
573:
571:
570:Living people
568:
566:
563:
561:
558:
557:
555:
534:
530:
524:
521:
509:
503:
500:
489:
485:
481:
480:The Telegraph
477:
470:
467:
454:
450:
444:
441:
429:
425:
419:
416:
411:
407:
401:
398:
386:
382:
376:
373:
362:on 2009-04-19
361:
357:
351:
348:
336:
333:
327:
324:
312:
311:
306:
299:
297:
293:
281:
277:
271:
268:
256:
255:
250:
243:
240:
228:
224:
218:
215:
208:
206:
204:
200:
196:
188:
186:
184:
180:
176:
172:
168:
164:
160:
156:
155:Biostatistics
152:
148:
143:
140:
136:
132:
129:
126:
118:
116:
114:
110:
106:
102:
98:
94:
93:Hal V. Barron
85:
82:
78:
74:
70:
67:
63:
60:
57:
53:
50:
46:
43:
39:
34:
31:
27:
23:Hal V. Barron
20:
536:. Retrieved
532:
523:
511:. Retrieved
502:
491:. Retrieved
479:
469:
457:. Retrieved
452:
443:
431:. Retrieved
427:
418:
409:
400:
388:. Retrieved
384:
375:
364:. Retrieved
360:the original
350:
338:. Retrieved
334:
326:
314:. Retrieved
310:The Guardian
308:
283:. Retrieved
270:
258:. Retrieved
252:
242:
230:. Retrieved
226:
217:
192:
167:angiogenesis
151:Epidemiology
144:
141:
137:
133:
130:
122:
92:
91:
65:Institutions
48:
560:1962 births
538:13 February
459:13 February
433:13 February
390:13 February
340:13 February
232:13 February
554:Categories
493:2022-10-19
366:2014-06-04
280:Altos Labs
209:References
163:thrombosis
159:Cardiology
105:Altos Labs
488:0307-1235
189:Education
125:Genentech
77:Genentech
59:Physician
513:15 April
385:Gene.com
316:June 19,
227:Cnbc.com
103:venture
71:(UCSF),
285:19 June
260:19 June
223:"Wires"
486:
406:"Home"
119:Career
109:Calico
55:Fields
540:2019
515:2019
484:ISSN
461:2019
435:2019
392:2019
342:2019
318:2022
287:2022
262:2022
234:2019
165:and
153:and
181:at
556::
531:.
482:.
478:.
451:.
426:.
408:.
383:.
307:.
295:^
278:.
251:.
225:.
205:.
185:.
115:.
79:,
75:,
40:,
35:,
542:.
517:.
496:.
463:.
437:.
412:.
394:.
369:.
344:.
320:.
289:.
264:.
236:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.